Trial Profile
A Double-blind, Placebo-controlled Phase II Study of Anastrozole in Patients With Pulmonary Arterial Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 23 Oct 2016 New trial record
- 07 Sep 2016 Primary endpoint (To assess the effects of anastrozole vs. placebo on tricuspid annular plane systolic excursion (TAPSE)) has been met ,according to the results published in the American Journal of Respiratory and Critical Care Medicine.
- 07 Sep 2016 Primary endpoint (To assess the effects of anastrozole vs. placebo on the plasma estradiol (E2)level) has been met, according to the results published in the American Journal of Respiratory and Critical Care Medicine.